Matsui Takanori

マツイタカノリ | Matsui Takanori

Affiliation and department：

Research field (4)： Food sciences , Chemical biology , Laboratory animal science , Cell biology

Research keywords (9)： physiologically functional food , Advanced Glycation End-products , Pigment Epithelium Derived Factor , peptide , aptamer , insulin resistance , diabetic complication , 細胞生物学 , Cell Biology

Research theme for competitive and other funds (16)：

2025 - 2028 敗血症性急性呼吸窮迫症候群に対する核酸医薬RAGEアプタマーによる革新的治療法の開発
2024 - 2027 Aptamer Raised Against Receptor for Advanced Glycation End Products (RAGE) Improves Survival Rate in Septic Acute Kidney Injury Mice
2023 - 2026 Development of an Innovative Therapy Utilizing RAGE Aptamer to Achieve Zero Mortality in Neonatal Necrotizing Enterocolitis.
2023 - 2026 Development of a novel therapeutic approach for diabetic nephropathy by nucleic acid medicine (DNA aptamer).
2022 - 2025 内因性一酸化炭素COの産生調節機構の解明と新規メディカルガスによる治療基盤の構築

Show all

Papers (238)：

Takanori Matsui, Tatsuya Sakaguchi, Yuichiro Higashimoto, Yuri Nishino, Ami Sotokawauchi, Yoshinori Koga, Sho-ichi Yamagishi. Sulforaphane inhibits cardiac fibrosis induced by advanced glycation end product-receptor axis through its anti-oxidative property. Acta Diabetologica. 2025
Matsui Takanori, Kawakita Ryuji, Yamagishi Sho-ichi. Combination of celery and paeonia albiflora extracts prepared according to the Japanese standards of quasi-drug ingredients inhibits advanced glycation end products formation in vitro. Diabetes Frontier Online. 2025. 12. e1-002. 001-001
Takanori Matsui, Ami Sotokawauchi, Yuri Nishino, Yoshinori Koga, Sho-ichi Yamagishi. Apixaban Inhibits Progression of Experimental Diabetic Nephropathy by Blocking Advanced Glycation End Product-Receptor Axis. International Journal of Molecular Sciences. 2025. 26. 7. 3007-3007
Matsui Takanori, Maru Isafumi, Yamagishi Sho-ichi. Inhibition of formation of advanced glycation end products by S-allylcysteine. Diabetes Frontier Online. 2025. 12. e1-001. 001-001
Takanori Matsui, Ami Sotokawauchi, Yuri Nishino, Yoshinori Koga, Sho-ichi Yamagishi. Empagliflozin ameliorates renal and metabolic derangements in obese type 2 diabetic mice by blocking advanced glycation end product-receptor axis. Molecular Medicine. 2025. 31. 1

ｍore...

MISC (230)：

松井孝憲, 山岸昌一. 抗加齢医療を目指した考える食と栄養食品由来の成分によるAGEsの抑制効果. 日本抗加齢医学会総会プログラム・抄録集. 2024. 24回. 128-128
松井孝憲, 越智耀亮, 井上敬太郎, 物部航平, 坂本寛, 青木俊介, 平順一. Grb14を標的として計算スクリーニングで得られた阻害剤はラットの経口糖負荷試験を改善する. 日本抗加齢医学会総会プログラム・抄録集. 2024. 24回. 276-276
八島広典, 寺崎道重, 外川内亜美, 松井孝憲, 齋藤智美, 森雄作, 大坂直也, 小原信, 福井智康, 山岸昌一. メトホルミンはAGEsに惹起されたマクロファージの泡沫化を抑制する. 糖尿病. 2024. 67. Suppl.1. S-186
寺崎道重, 森雄作, 八島広典, 斎藤智美, 大坂直也, 藤川大輝, 竹鼻伸晃, 高橋範之, 江波戸彩乃, 尾町健将, et al. Glucose-dependent insulinotropic polypeptideは終末糖化産物(AGEs)に惹起されたヒト単球由来マクロファージ泡沫化を抑制する. 糖尿病. 2024. 67. Suppl.1. S-290
Hamida Khanom, 坪井耀大, 川端理希, 松井孝憲, 伊藤崇志. タウリン介入はCCL4誘発マウス肝障害における老化発現を抑制する(Taurine intervention attenuates senescence expression in CCL4 induced mice liver injury). 日本臨床薬理学会学術総会抄録集. 2024. 44回. 2-J3

ｍore...

Patents (3)：

Education (4)：

2000 - 2004 Kyushu Institute of Technology
1997 - 2000 Kyushu Institute of Technology
1995 - 1997 Kyushu Institute of Technology School of Computer Science and Systems Engineering
1990 - 1995 National Institute of Technology, Fukui College

Professional career (1)：

(BLANK) (Kyushu Institute of Technology)

Association Membership(s) (7)：

Japanese Society of Food Chemistry , 日本抗加齢医学会 , JAPANESE SOCIETY OF NEPHROLOGY , THE MOLECULAR BIOLOGY SOCIETY OF JAPAN , NUCLEIC ACIDS THERAPEUTICS SOCIETY OF JAPAN , THE JAPAN DIABETES SOCIETY , The Japanese Biochemical Society

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page